Article Type: Generic

U of O and NRCan plan joint research facility

The Univ of Ottawa is hoping that a integrated collaborative R&D initiative with Natural Resources Canada’s Geological Survey of Canada (GSC) will help to revive a once-proud Canadian institution and train a new generation of world class geologists.

$100 million to launch fund of funds

Alberta takes aim at province’s high-tech sectors with aggressive action plan

Alberta has unveiled an integrated action plan to stimulate technology company creation and commercialization, highlighted by a $100-million contribution to seed a fund of funds through the recently created Alberta Enterprise Corp.

Terry Matthew’s sounds alarm bell for future of Canadian high-tech sector

RE$EARCH MONEY Conference

Canada’s ability to grow global flagship companies from start-ups is being threatened by the precarious state of the Canadian high-tech sector and government must shoulder much of the blame says the country’s most prolific and successful serial entrepreneur.

Lazaridis increases commitment to Perimeter

Mike Lazaridis has boosted his personal support for the Perimeter Institute for Theoretical Physics (PI) to $150 million with a new $50-million donation to the Waterloo ON-based research institution. The latest donation from the president and co-CEO of Research in Motion closely follows the appointment of Dr Neil Turok as PI’s new executive director (R$ May 20/08).

Cancer genome consortium enhances Toronto’s image as life sciences centre

The selection of Toronto’s as the global and data headquarters for an ambitious $1-billion global genome consortium to combat cancer promises to dramatically increase the city’s life sciences activity and profile, says the researcher who led the effort to attract the initiative to the region.

Saskatoon’s vaccine development cluster enhanced with new commercialization arm

A new consortium created to bring critical yet commercially promising vaccines to market is bolstering Saskatoon’s growing reputation as a global powerhouse for human and animal vaccine development. Supported by the federal Centres of Excellence in Commercialization and Research (CECR) program, the Pan-Provincial Vaccine Enterprise (PREVENT) intends to draw on vaccine research strengths from at least three organizations

In-kind support of $10.